Side Effects of Prostate Cancer Therapy Cause High Emotional Distress, Study Confirms

Side Effects of Prostate Cancer Therapy Cause High Emotional Distress, Study Confirms
Urinary, sexual, and bowel dysfunction, which are side effects of prostate cancer treatment, can cause elevated emotional distress for at least two years post-treatment, a new study shows. The study, titled “Worse urinary, sexual, and bowel function cause emotional distress and vice versa in men treated for prostate cancer,” was published in The Journal of Urology. In the United States alone, more than 2.8 million prostate cancer survivors received definitive therapy, such as surgery or radiotherapy. Many of these men tend to experience some degree of urinary incontinence, and the majority experience erectile dysfunction. Furthermore, radiation and brachytherapy have been associated with bowel pain and urgency. These side effects have been associated with a negative impact on patients’ quality of life. Researchers set out to determine whether urinary, bowel, and sexual dysfunction induced by prostate cancer therapy also caused emotional distress, and vice versa. The study recruited 1,148 men diagnosed with localized prostate cancer who received either surgery or radiotherapy. Participants’ urinary, sexual, and bowel function were determined using the Expanded Prostate Cancer Index Composite (EPIC). Then, emotional distress was determined using the Distress Thermometer. The assessments were conducted pre-treatment, at six weeks, and then at six, 12, 18, and 24 months post-treatment. Results showed that men with worse urinary, bowel, and sexual functioning tended to report more emotional distress than patients with better functioning at all time points after treatment. Re
Subscribe or to access all post and page content.

Tagged , , , , , , .

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

Leave a Comment

Your email address will not be published. Required fields are marked *